Mereo BioPharma Group PLC ADR (MREO) — Capital Reinvestment Ratio

Latest as of June 2021: 0.02x

Mereo BioPharma Group PLC ADR (MREO) has a Capital Reinvestment Ratio of 0.02x as of June 2021, meaning it reinvests 0% of its operating cash flow ($13.75 Million) in capital expenditures ($267.50K). Check Mereo BioPharma Group PLC ADR (MREO) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$13.75 Million

USD

Capital Expenditures

$267.50K

USD

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for Mereo BioPharma Group PLC ADR (None–None)

Year-by-year Capital Reinvestment Ratio for Mereo BioPharma Group PLC ADR from None to None. See free cash flow generation of Mereo BioPharma Group PLC ADR to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow